AI-driven clinical intelligence is transforming medical imaging, with point-of-care diagnostics projected to reach $70.92 billion by 2032. The CMS ACCESS Model launching in July 2026 will reward outcome-based care, driving adoption of software-defined imaging platforms. Key players including VentriPoint Diagnostics, Butterfly Network, Hyperfine, Hologic, and GE HealthCare are advancing portable, AI-powered diagnostic solutions that deliver hospital-grade precision at the bedside, reducing facility overhead while improving patient outcomes.

The Russell 2000 index reached an all-time high after the Federal Reserve signaled potential interest rate cuts, boosting small-cap stocks and providing cheaper borrowing opportunities for smaller companies.

The global AI in healthcare market is projected to reach nearly $700 billion by 2034, growing at 38.5% annually. Companies are developing advanced AI diagnostic technologies targeting areas like diabetic retinopathy, cardiac screening, and chronic disease management, with increasing FDA approvals and commercial potential.

Butterfly Network reported Q2 2025 results with 9% revenue growth, record 63.7% gross margin, and narrowed losses. The company revised full-year revenue guidance lower and is focusing on AI-driven software and international expansion.

The article discusses the rapid adoption of artificial intelligence (AI) in the healthcare industry, with several tech and biotech companies making significant strides. It highlights the potential of AI to transform various aspects of healthcare, including early disease detection and intelligent therapeutics.

The global ultrasound image analysis software market is expected to grow from $0.913 billion in 2024 to $2.2 billion by 2035, driven by advancements in ultrasound technology, rising chronic diseases, and the integration of AI and machine learning.

The global healthcare cognitive computing market is expected to grow from $10.81 billion in 2024 to $150.25 billion by 2035, driven by the adoption of cloud services, increase in chronic diseases, and the need for advanced patient data analysis.

Butterfly Network's stock surged 26.9% after the company announced the commercial launch of its third-generation handheld point-of-care ultrasound system, Butterfly iQ3, in Europe. The device's strong uptake in the U.S. market and its advanced features are driving investor optimism.

The global AI in diagnostics market is expected to grow at a CAGR of 23.1% from 2024 to 2034, reaching a valuation of $14.76 billion. The use of AI in diagnostics is revolutionizing patient care, improving accuracy and efficiency, and making diagnostic services more accessible.

Butterfly Network's Chief Technology Officer, Andrei G. Stoica, sold $1,486 worth of Class A Common Stock as part of a tax withholding policy. The transaction was routine and not made at Stoica's discretion.

Butterfly Network (BFLY) uses proprietary Ultrasound-on-Chip technology to streamline the bladder scanning process.

We have narrowed our search to five medical info systems stocks that have strong growth potential for 2024. These stocks are: HIMS, BFLY, ENOV, LUNG, DH.